Skip to content
Buy This GLP
← Research
Safety

How Do You Spot Fake Ozempic? What Counterfeit-Pen Reports Show

FDA has flagged three counterfeit Ozempic 1 mg lots in the U.S. supply chain since December 2023. One shares its number with authentic pens, so the label layout is the tell.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team6 min read
FDA alerts: counterfeit Ozempic 1 mg in the U.S.Dec 21, 2023Lot NAR0074thousands of units seizedApr 14, 2025Lot PAR0362several hundred unitsDec 5, 2025Lot PAR1229dozens of unitsPAR1229 is also an authentic lot. Check the label layout.

Start with the lot number and the label layout. FDA has flagged three counterfeit lots of Ozempic 1 mg in the U.S. supply chain: NAR0074, PAR0362 and PAR1229 [1]. The December 2023 seizure ran to thousands of units. PAR1229 is also an authentic lot, so the tell is on the pen itself. Counterfeit labels print “EXP/LOT” to the left of the date and lot number, while authentic ones print it above.

When you verify the dispensing pharmacy, use its state licensing record and contact the pharmacy directly. The lot and label checks below address specific counterfeits identified by FDA. A matching package alone cannot verify where the medication came from.

The three FDA alerts, by date

December 21, 2023: FDA had seized thousands of units of counterfeit Ozempic 1 mg [1]. It named lot NAR0074 with serial number 430834149057. The needles were counterfeit, so their sterility could not be confirmed and the infection risk was higher.

That alert also listed the pen label, the patient and professional information, and the carton as confirmed counterfeit components [1]. FDA knew of five adverse events from that lot, and none was serious.

April 14, 2025: Novo Nordisk told FDA of several hundred counterfeit units on April 3 [1]. FDA seized them on April 9, and the alert named lot PAR0362 with serial numbers starting 51746517.

December 5, 2025: FDA had seized dozens of units labeled lot PAR1229 [1]. That number also appears on authentic pens. The counterfeit prints the “EXP/LOT” text on the left side of the expiration date and lot number.

FDA says pens from lot PAR1229 received through Novo Nordisk’s Patient Assistance Program are authentic [1]. Testing of the seized product was still under way when that alert was posted.

What to check on a pen or package

Each check below is a condition, and a product that fails any one of them should not be injected.

The form must match the label. Ozempic injection is supplied as multi-dose pens and single-dose prefilled syringes [3]. A vial labeled Ozempic is not a listed presentation on that label.

The solution must be clear and colorless. The label says not to use Ozempic if particles or coloration are seen [3].

Check the lot, serial number and label together against the relevant alert. Authentic pens also carry lot PAR1229, so use the label details FDA provides for that alert. Pharmacists can confirm a batch with Novo Nordisk customer care at 1-800-727-6500 [1].

The package must look like earlier fills. FDA lists medicine that looks different from before, or arrives in damaged packaging, as a warning sign [7]. Ask the dispensing pharmacy to check any differences before using it.

What fake semaglutide has contained

The harm on record is not only a weak dose. In Italy, a 31-year-old woman was admitted in a hypoglycemic coma after injecting “Ozempic” bought from a website [4]. Toxicology found insulin in the vial instead of semaglutide.

Two Dutch cases followed the same pattern [5]. Neither patient had diabetes or obesity, and both had obtained semaglutide without a prescription. Both arrived in a coma with severe hypoglycemia. The authors attributed both cases to synthetic insulin exposure.

These reports describe people whose clinicians investigated possible insulin exposure after severe hypoglycemia [4] [5]. Low blood sugar alone cannot identify the contents of an injection.

What the European reports add

A study searched the EU’s pharmacovigilance database from 2018 through 2025 [6]. It identified 234 reports involving suspected counterfeit semaglutide. The study classified 209 of those reports (89.3%) as serious.

Vomiting, nausea and hypoglycemia were reported most often [6]. Against other semaglutide reports, suspected counterfeit cases more often included hypoglycemia or reports that the product did not work. The study could compare reporting patterns. It could not estimate how often these problems occur among people who use the products.

Where the risk sits

FDA separates counterfeits from a second problem [2]. Some compounded semaglutide and tirzepatide carries a label naming a pharmacy that does not exist. Other labels name a licensed pharmacy that did not make the product.

If you are evaluating an online semaglutide offer, start with FDA’s advice to fill a valid prescription at a state-licensed pharmacy [2]. Researchers who ordered semaglutide from sites that skipped prescriptions found problems that were apparent only after purchase and testing. A product listing cannot tell you what will arrive.

Keep the package and contact the dispensing pharmacist if you suspect a counterfeit. FDA advises against using products that match its counterfeit alerts and accepts reports through its safety reporting portal [1].

Frequently asked

How can you tell if Ozempic is fake?
Check the lot and serial against FDA's alerts (NAR0074, PAR0362 and PAR1229), check that the solution is clear and colorless, and check the form: the label lists pens and prefilled syringes, not vials. For lot PAR1229, which is also an authentic lot, FDA says the counterfeit prints EXP/LOT to the left of the date instead of above it.
Has counterfeit Ozempic been found in the U.S.?
Yes. FDA reported counterfeit Ozempic 1 mg in the legitimate U.S. supply chain in December 2023, April 2025 and December 2025, and seized units each time.
What is in fake Ozempic?
Often nobody knows until it is tested. In published cases from Italy and the Netherlands, products sold as semaglutide contained insulin and caused hypoglycemic coma. FDA says counterfeits can hold the wrong ingredient, too much or too little, or none at all.

Sources

  1. [1] U.S. Food and Drug Administration (2025). FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain FDA, Drug Alerts and Statements (updates dated December 21, 2023, April 14, 2025 and December 5, 2025). Source
  2. [2] U.S. Food and Drug Administration (2026). FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss FDA, Drug Alerts and Statements (content current as of September 1, 2026). Source
  3. [3] Novo Nordisk (2026). OZEMPIC (semaglutide) injection, for subcutaneous use — prescribing information DailyMed, U.S. National Library of Medicine. Source
  4. [4] Antonacci G, et al. (2026). Hypoglycaemic coma induced by a falsified semaglutide product: a case report European Journal of Hospital Pharmacy. PMID 41125326
  5. [5] Stammers J, et al. (2026). [Insulin intoxications caused by falsified semaglutide] Nederlands Tijdschrift voor Geneeskunde. PMID 42390457
  6. [6] Zinzi A, et al. (2026). Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance Frontiers in Pharmacology. PMID 42137313
  7. [7] U.S. Food and Drug Administration (2024). How to Buy Medicines Safely From an Online Pharmacy FDA BeSafeRx. Source

More in Safety